NHS Diabetes Prevention Programme in England: formative evaluation of the programme in early phase implementation

BMJ Open
Linda PennFalko F Sniehotta

Abstract

Evaluation of the demonstrator phase and first wave roll-out of the National Health Service (NHS) Diabetes Prevention Programme (DPP) in England. To examine: (1) intervention design, provision and fidelity assessment procedures; (2) risk assessment and recruitment pathways and (3) data collection for monitoring and evaluation. To provide recommendations informing decision makers on programme quality, improvements and future evaluation. We reviewed programme documents, mapping against the NHS DPP specification and National Institute for Health and Care Excellence (NICE) public health guideline: Type 2 diabetes (T2D) prevention in people at high risk (PH38), conducted qualitative research using individual interviews and focus group discussions with stakeholders and examined recruitment, fidelity and data collection procedures. Seven NHS DPP demonstrator sites and, subsequently, 27 first wave areas across England. Intensive behavioural intervention with weight loss, diet and physical activity goals. The national programme specifies at least 13 sessions over 9 months, delivered face to face to groups of 15-20 adults with non-diabetic hyperglycaemia, mainly recruited from primary care and NHS Health Checks. Participants for qualitat...Continue Reading

References

Feb 1, 1986·Quality Assurance and Utilization Review : Official Journal of the American College of Utilization Review Physicians·A Donabedian
May 3, 2001·The New England Journal of Medicine·J TuomilehtoUNKNOWN Finnish Diabetes Prevention Study Group
Feb 8, 2002·The New England Journal of Medicine·William C KnowlerUNKNOWN Diabetes Prevention Program Research Group
Dec 28, 2002·Diabetes Care·William H HernanUNKNOWN Diabetes Prevention Program Research Group
Mar 1, 2003·Diabetes Care·Jaana Lindström, Jaakko Tuomilehto
Mar 2, 2005·Annals of Internal Medicine·William H HermanUNKNOWN Diabetes Prevention Program Research Group
Apr 18, 2006·Lancet·Peter TugwellUNKNOWN Cochrane Equity Field Editorial Team
Mar 16, 2007·Public Health Reports·Peter E H SchwarzJan Schulze
Oct 2, 2007·Lancet·Michael Marmot, UNKNOWN Commission on Social Determinants of Health
Dec 26, 2007·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Peter E H SchwarzJaakko Tuomilehto
Oct 1, 2008·BMJ : British Medical Journal·Peter CraigUNKNOWN Medical Research Council Guidance
Mar 20, 2009·BMJ : British Medical Journal·Julia Hippisley-CoxPeter Brindle
Oct 8, 2009·The Journal of Clinical Endocrinology and Metabolism·Montserrat BalsellsR Corcoy
Mar 4, 2010·Research in Nursing & Health·Susan M BreitensteinBarbara Resnick
Dec 15, 2010·The Cochrane Database of Systematic Reviews·Vivian WelchJanet Smylie
Aug 10, 2011·Archives of Internal Medicine·Toshikazu SaitoUNKNOWN Zensharen Study for Prevention of Lifestyle Diseases Group
Sep 10, 2011·Science·David SpiegelhalterIan Short
Oct 19, 2011·BMJ : British Medical Journal·Gerd Gigerenzer
Jul 14, 2012·BMJ : British Medical Journal·Hilary ChattertonUNKNOWN Programme Development Group
Aug 30, 2012·Trials·Edward D JanusUNKNOWN Melbourne Diabetes Prevention Study research group
Nov 2, 2014·BMJ : British Medical Journal·Mahiben MaruthappuBruce Keogh
Mar 21, 2015·BMJ : British Medical Journal·Graham F MooreJanis Baird
Sep 9, 2015·BMJ : British Medical Journal·Eleanor BarryTrisha Greenhalgh
Dec 2, 2015·Translational Behavioral Medicine·Rachel G TabakRoss C Brownson
Mar 24, 2016·BMJ : British Medical Journal·Ingrid Torjesen
Jul 13, 2016·PLoS Medicine·Martin White
Sep 18, 2016·BMJ : British Medical Journal·Adrian O'Dowd
Feb 25, 2017·BMJ : British Medical Journal·Nicola Guess
Dec 22, 2017·Diabetic Medicine : a Journal of the British Diabetic Association·E BarronJ Valabhji

❮ Previous
Next ❯

Citations

Nov 23, 2018·Diabetic Medicine : a Journal of the British Diabetic Association·J Fagg, J Valabhji
Jan 1, 2019·Diabetic Medicine : a Journal of the British Diabetic Association·R TaylorD Paul
Mar 30, 2018·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Helen TwohigCaroline Mitchell
May 1, 2019·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·Samantha RobertsTrisha Greenhalgh
Apr 8, 2018·Clinical Medicine : Journal of the Royal College of Physicians of London·Tahseen A Chowdhury
Dec 7, 2019·Diabetic Medicine : a Journal of the British Diabetic Association·R E HawkesD P French
Jul 21, 2020·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Jillian A PattersonJonathan M Morris
Dec 25, 2019·BMC Health Services Research·Jonathan StokesPaul Wilson
Sep 18, 2020·BMC Public Health·Lou AtkinsFabi Lorencatto
Nov 29, 2020·BMC Health Services Research·Rhiannon E HawkesDavid P French
Feb 10, 2021·International Journal of Behavioral Medicine·Rhiannon E HawkesDavid P French
Feb 14, 2021·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·David P FrenchElaine Cameron
Feb 13, 2021·Diabetic Medicine : a Journal of the British Diabetic Association·Tom PierseCiaran O'Neill
Mar 9, 2021·Expert Review of Pharmacoeconomics & Outcomes Research·Samuel N FrempongGurdeep S Sagoo
May 15, 2021·The International Journal of Behavioral Nutrition and Physical Activity·Rhiannon E HawkesDavid P French

❮ Previous
Next ❯

Software Mentioned

NVivo

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.